Interleukin-1 signaling is dependent on free thiols

G F Böl1, F Tewes, R Brigelius-Flohé

  • 1German Institute of Human Nutrition, Department of Vitamins and Atherosclerosis, Potsdam-Rehbrücke. boel@www.dife.de

Insights

Interleukin-1 receptor type I (IL-1-RI) signaling involves redox regulation. Thiol modification inhibits IL-1-induced phosphorylation in T cells and endothelial cells, suggesting free thiols are key targets.

Area of Science:

  • Cellular signaling pathways
  • Redox biology
  • Immunology

Background:

  • Interleukin-1 receptor type I (IL-1-RI) activation initiates downstream signaling, including IRAK kinase activation and NF-kappaB translocation.
  • The IL-1 signaling cascade involves oxidative processes, indicating potential redox regulation mechanisms.

Purpose of the Study:

  • To investigate the role of redox regulation in IL-1 signal transduction.
  • To identify potential targets for redox modulation within the IL-1 signaling pathway in both lymphocyte and endothelial cells.

Main Methods:

  • Utilized thiol-modifying agents (diamide, menadione, phenylarsine oxide) to probe redox sensitivity.
  • Analyzed IL-1-induced phosphorylation of specific protein substrates (60 kD and 85 kD) in EL-4 (T cell) and ECV 304 (endothelial) cell lines using Western blotting or similar techniques.
  • Assessed the impact of thiol modification on IL-1-mediated signaling events.

Main Results:

  • Thiol modification significantly inhibited the IL-1-induced phosphorylation of a 60 kD substrate in both T cells and endothelial cells.
  • A second substrate, approximately 85 kD, was phosphorylated in endothelial cells upon IL-1 stimulation, and this phosphorylation was also sensitive to thiol modification.
  • These findings demonstrate that IL-1 signal transduction is dependent on free thiols.

Conclusions:

  • IL-1 signal transduction pathways are subject to redox regulation.
  • Free thiols in specific protein substrates are critical for IL-1-mediated signaling in lymphocytes and endothelial cells.
  • These results highlight novel targets for therapeutic intervention in inflammatory and immune responses.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...